Home About Us Contact Us

 

Table of Content Volume 13 Issue 3 - March 2020

 

Study of profile of patients with clinically isolated syndrome: A hospital based prospective study

 

Shivakumar K Masaraddi1*, Goutam Ganguly2, Alok Pandit3, Arijit Ray4

 

1Assistant Professor, Department of General Medicine, S. Nijalingappa Medical College and HSK Hospital, Bagalkot, Karnataka, INDIA.

2Professor, 3Associate Professor, 4Assistant Professor, Department of Neurology, Bangur Institute of Neurosciences and Ipgmeandr, Kolkata, West Bengal, INDIA.

Email: skmneuro@gmail.com  

 

REFERENCES

  1. Scalfari A, Neuhaus A, Degenhardt A et.al.,. The natural history of MS: a geographically based study 10: relapse and long-term disability. Brain 2010;133:1914-29.
  2. Confavreux C, Vukusic S. Natural history of MS: a unifying concept. Brain 2006;129:606-16.
  3. Orton SM, Herrera BM, Yee IM et.al.,. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5(11):932-36.
  4. Goodin DS, Frohman EM, Garmany GP, et.al.,. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002;58(2):169-178.
  5. Richards RG, Sampson FC, Beard SM, Tappenden P. A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. Health Technol Assess 2002;6(10):l-73.
  6. Bhatia M, Behari M, Ahuja GK. Multiple sclerosis in India: AIIMS experience. J Assoc Physicians India 1996;44:765-67.
  7. Brex PA, Ciccarelli O, O’Riordan OJI. Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. The New England Journal of Medicine 2002;346(3)158-64.
  8. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M. Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. Journal of Neurology Neurosurgery and Psychiatry 1966;29(1)60-8.
  9. Wadia NH, Trikannad VS, Krishnaswamy PR. HLA antigens in multiple sclerosis amongst Indians. Journal of Neurology Neurosurqery and Psychiatry 1981;44(9):849-51.
  10. Kelly MA, Jacobs KH, Penny MA et.al.,. An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Affo-Caribbean ethnic origin. Tissue Antigens 1995;45(3):197-202.
  11. Kankonkar S, Jeyanti G, Singhal BS, Shankarkumar U. Evidence for novel DRB1G15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Human Immunology 2003;64(4):478-82.
  12. Singhal BS, Wadia NH. Profile of multiple sclerosis in the Bombay region: on the basis of critical clinical appraisal. Journal of the Neurological Sciences 1975;26(2):259-70.
  13. Jacobs L, Beck R, Simon J et.al.,. Intramuscular interferon beta-la therapy initiated during the first demyelinating event in multiple sclerosis. N Engl J Med 2000;343:898-904.
  14. Frohman EM, Goodin DS, Calabresi PA et.al.,, The utility of MRI in suspected MS: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2003;61(5):602-11.
  15. Alroughani R, Al Hashel J, Lamdhade S, Ahmed SF. Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 RevisedMcDonald Criteria. International Scholarly Research Network ISRN Neurology 2012. (Article ID 792192, 6 pages doi:10.5402/2012/792192).
  16. Singhal BS. Multiple sclerosis and related demyelinating disorders in Indian context. Neurol India 1987;35:1-12.
Journal Menu MIJOMED Medpulse Manuscript Submission Subscription Aim & Scope Peer Review Process Publication Ethics & Malpractice Statement Open Access Statement Plagiarism Policy Editorial Board Indexing Current Issue Publication Charges Archives Authors Information Copyright & Licensing Privacy Statement Contact Us